Compounds > pirodavir
Page last updated: 2024-08-25

pirodavir and rupintrivir

pirodavir has been researched along with rupintrivir in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feil, SC; Hamilton, S; Krippner, GY; Lin, B; Luttick, A; McConnell, DB; Morton, CJ; Nearn, R; Parker, MW; Ryan, J; Stanislawski, PC; Tucker, SP; Watson, KG1
Aguayo, E; Birkus, G; Cihlar, T; Jordan, R; Lee, G; Mello, C; Rodriguez, M1
Franco, D; Froeyen, M; Hilgenfeld, R; Leyssen, P; Neyts, J; Tijsma, A; Tucker, S1

Other Studies

3 other study(ies) available for pirodavir and rupintrivir

ArticleYear
An Orally Available 3-Ethoxybenzisoxazole Capsid Binder with Clinical Activity against Human Rhinovirus.
    ACS medicinal chemistry letters, 2012, Apr-12, Volume: 3, Issue:4

    Topics:

2012
Multiple classes of antiviral agents exhibit in vitro activity against human rhinovirus type C.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3

    Topics: Antiviral Agents; Common Cold; Dose-Response Relationship, Drug; HeLa Cells; Humans; In Vitro Techniques; Isoxazoles; Oxadiazoles; Oxazoles; Phenylalanine; Piperidines; Pyridazines; Pyrrolidinones; Replicon; Rhinovirus; RNA, Viral; Tubercidin; Valine; Virus Replication

2014
The capsid binder Vapendavir and the novel protease inhibitor SG85 inhibit enterovirus 71 replication.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:11

    Topics: Antiviral Agents; Benzimidazoles; Capsid; Capsid Proteins; Drug Resistance, Viral; Enterovirus A, Human; Enterovirus Infections; Isoxazoles; Molecular Docking Simulation; Oximes; Phenylalanine; Piperidines; Protease Inhibitors; Protein Binding; Pyridazines; Pyrrolidinones; Sulfonamides; Valine; Virus Replication

2014